鼻内接种细菌样颗粒佐剂疫苗对肠道感染保护效果的评估
本研究在C57BL/6小鼠中用啮齿柠檬酸杆菌(Citrobacter rodentium)模型评估鼻内接种细菌样颗粒(BLP)佐剂疫苗对肠道感染的保护效果。鼻内接种Intimin联合BLP(BLP+I)可诱导强烈的Intimin特异性肠道分泌型IgA产生,减少粪便细菌载量并几乎完全抑制结肠增生;而胃肠外接种氢氧化铝佐剂Intimin未能诱导肠道Intimin特异性IgA,保护效果差。
要点
- 鼻内接种BLP+I诱导强烈的Intimin特异性肠道分泌型IgA。
- BLP+I减少粪便细菌载量并几乎完全抑制结肠增生。
- 胃肠外氢氧化铝佐剂Intimin未诱导肠道IgA,保护效果差。
核心结论
- 鼻内接种BLP佐剂疫苗在啮齿柠檬酸杆菌模型中可控制肠道感染,其保护效果与黏膜IgA应答相关。
- 作者指出本研究未阐明BLP+I鼻内免疫抗啮齿柠檬酸杆菌感染的确切保护机制,需进一步阐明其机制。
研究设计与样本
- 在C57BL/6小鼠中使用啮齿柠檬酸杆菌(Citrobacter rodentium)模型评估鼻内BLP佐剂疫苗接种对肠道感染的保护效果。
主要发现
- 鼻内接种Intimin联合BLP(BLP+I)诱导强烈的Intimin特异性肠道分泌型IgA产生。
- BLP+I减少粪便细菌载量并几乎完全抑制结肠增生,结肠增生是啮齿柠檬酸杆菌感染小鼠的特征性症状。
- 胃肠外接种氢氧化铝佐剂Intimin未能诱导肠道Intimin特异性IgA产生,对啮齿柠檬酸杆菌感染保护效果差。
局限性
- 本研究未阐明BLP+I鼻内免疫抗啮齿柠檬酸杆菌感染的确切保护机制,需进一步阐明鼻内BLP+I免疫的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mucosal vaccination presents a promising complement to parenteral vaccination. Bacterium-like particles (BLPs), peptidoglycan structures prepared from lactic acid bacteria, are explored as potential nasal vaccine adjuvants for respiratory infections. To date, studies on BLP-adjuvanted nasal vaccines against intestinal infections have remained limited. In this study, we demonstrated the efficacy of intranasal BLP-adjuvanted vaccination in controlling intestinal infections using the Citrobacter rodentium (C. rodentium) model in C57BL/6 mice. Intranasal vaccination of Intimin, an adhesin critical for intimate bacterial adhesion to colonic epithelial cells, combined with BLP (BLP+I) elicited robust Intimin-specific intestinal secretory IgA production, reduced bacterial load in feces and almost completely inhibited colonic hyperplasia, a characteristic symptom of C. rodentium infection in mice. Conversely, parenteral vaccination with Alhydrogel-adjuvanted Intimin failed to induce intestinal Intimin-specific IgA production, resulting in poor protection against C. rodentium infection. This underscores the pivotal role of mucosal IgA responses elicited by intranasal immunization in its protective efficacy. As this study did not delineate the precise protective mechanism conferred by BLP+I intranasal immunization against C. rodentium infection, further elucidation of the mechanisms underlying intranasal BLP+I immunization is required.
引用
- Tsujii A, Takahashi K, Harada H, et al. Evaluation of the protective effect of the intranasal vaccines adjuvanted with bacterium-like particles against intestinal infection. Vaccine. 2024. PMID: 38763852. doi:10.1016/j.vaccine.2024.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。